Omnicell, Inc.  

(Public, NASDAQ:OMCL)   Watch this stock  
Find more results for OMCL
-0.30 (-0.74%)
After Hours: 40.05 0.00 (0.00%)
Mar 28, 4:38PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 39.65 - 40.40
52 week 25.06 - 40.65
Open 40.20
Vol / Avg. 199,778.00/380,433.00
Mkt cap 1.50B
P/E 2,689.72
Div/yield     -
EPS 0.01
Shares 36.95M
Beta 0.82
Inst. own 97%
Feb 2, 2017
Q4 2016 Omnicell Inc Earnings Release (Estimated)
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 0.09% 0.09%
Operating margin -0.11% 0.94%
EBITD margin - 8.31%
Return on average assets 0.07% 0.08%
Return on average equity 0.15% 0.14%
Employees 2,444 -
CDP Score - -


590 E Middlefield Rd
MOUNTAIN VIEW, CA 94043-4008
United States - Map
+1-650-2516100 (Phone)
+1-650-2516266 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Omnicell, Inc. (Omnicell) is a provider of automation and business information solutions designed to enable healthcare systems to streamline the medication administration process and manage medical supplies for increased operational efficiency and enhanced patient safety. The Company operates through two operating segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment organizes the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems, and related software. The Medication Adherence segment primarily includes the manufacturing and selling of consumable medication blister cards, packaging equipment and ancillary products and services. Its product line includes OmniRx, SinglePointe, AnywhereRN, Omnicell and Pandora Data Analytics, Savvy Mobile Medication System, Central Pharmacy and Satellite Pharmacy Manager, Anesthesia Workstation and Advanced Interoperability products.

Officers and directors

Randall A. Lipps Chairman of the Board, President, Chief Executive Officer
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Peter J. Kuipers Chief Financial Officer, Executive Vice President
Age: 44
Bio & Compensation  - Reuters
Daniel S. Johnston Executive Vice President, Chief Legal and Administrative Officer
Age: 52
Bio & Compensation  - Reuters
J. Christopher Drew Executive Vice President of Sales and Marketing for North American Automation
Age: 50
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Nhat H. Ngo Executive Vice President - Strategy and Business Development
Age: 43
Bio & Compensation  - Reuters
Robin Gene Seim Executive Vice President, Global Automation and Medication Adherence
Age: 56
Bio & Compensation  - Reuters
Jorge R. Taborga Executive Vice President - Engineering and Integration Management Office
Age: 55
Bio & Compensation  - Reuters
James T. Judson Lead Independent Director
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Joanne B. Bauer Independent Director
Age: 60
Bio & Compensation  - Reuters
Vance B. Moore Independent Director
Age: 55
Bio & Compensation  - Reuters